切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2026, Vol. 13 ›› Issue (01) : 49 -55. doi: 10.3877/cma.j.issn.2095-8765.2026.01.007

综述

腹腔镜袖状胃切除术与Roux-en-Y胃旁路术对肥胖合并阻塞性睡眠呼吸暂停患者术后代谢及胃食管反流病影响的研究进展
杨兴源1,2, 向婷1,2, 周庆2,()   
  1. 1810000 西宁,青海大学研究生院
    2810000 西宁,青海省红十字医院胃肠外科
  • 收稿日期:2026-01-14 出版日期:2026-02-15
  • 通信作者: 周庆
  • 基金资助:
    青海省卫生健康委员会指导性计划课题(2022-wjzdx-89)

Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: research progress on the mechanisms underlying postoperative metabolic changes and gastroesophageal reflux disease in obese patients with obstructive sleep apnea

Xingyuan Yang1,2, Ting Xiang1,2, Qing Zhou2,()   

  1. 1Graduate School of Qinghai University, Xining 810000, China
    2Department of Gastrointestinal Surgery, Qinghai Red Cross Hospital, Xining 810000, China
  • Received:2026-01-14 Published:2026-02-15
  • Corresponding author: Qing Zhou
引用本文:

杨兴源, 向婷, 周庆. 腹腔镜袖状胃切除术与Roux-en-Y胃旁路术对肥胖合并阻塞性睡眠呼吸暂停患者术后代谢及胃食管反流病影响的研究进展[J/OL]. 中华胃食管反流病电子杂志, 2026, 13(01): 49-55.

Xingyuan Yang, Ting Xiang, Qing Zhou. Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: research progress on the mechanisms underlying postoperative metabolic changes and gastroesophageal reflux disease in obese patients with obstructive sleep apnea[J/OL]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2026, 13(01): 49-55.

本文系统比较腹腔镜袖状胃切除术(LSG)与Roux-en-Y胃旁路术(RYGB)对肥胖合并阻塞性睡眠呼吸暂停(OSAS)患者术后代谢影响的多种机制。胃食管反流病(GERD)作为OSAS的重要共病,二者存在双向加重的病理关系,术式对GERD的不同影响直接关乎OSAS的术后缓解效果。两种术式除通过体质量依赖机制减轻上气道脂肪沉积、缓解间歇性低氧与系统性炎症外,还通过胃肠激素重塑、胆汁酸信号激活与肠道菌群调控等非体质量依赖机制直接调节糖脂代谢。其中,RYGB在肠源性激素与胆汁酸调控方面更具优势,且兼具明确的抗反流作用;而LSG则通过强力抑制Ghrelin与增强GLP-1/PYY应答发挥代谢效益,还可通过调节GLP-1/DPP-4通路抑制氧化应激诱导的脂肪炎症,却存在诱发或加重GERD的风险。本文旨在为肥胖合并OSAS患者,尤其是合并GERD者,提供个体化术式选择的综合机制依据。

This article systematically compares the multiple mechanisms by which laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) affect postoperative metabolism in obese patients with obstructive sleep apnea (OSAS). As a key comorbidity of OSAS, gastroesophageal reflux disease (GERD) has a bidirectional pathological exacerbation relationship with OSAS, and the different effects of these two procedures on GERD are directly related to the postoperative remission of OSAS. In addition to reducing upper airway fat deposition and alleviating intermittent hypoxia and systemic inflammation through weight-dependent mechanisms, both procedures directly regulate glucose and lipid metabolism via non-weight-dependent mechanisms such as gastrointestinal hormone remodeling, bile acid signal activation, and gut microbiota regulation. Among them, RYGB shows superior advantages in the regulation of enteric hormones and bile acids, and has a definite anti-reflux effect; while LSG exerts metabolic benefits by strongly inhibiting ghrelin and enhancing GLP-1/PYY responses, and can also inhibit oxidative stress-induced adipose inflammation through regulating the GLP-1/DPP-4 pathway, but carries the risk of inducing or exacerbating GERD. This review aims to provide a comprehensive mechanistic basis for the individualized selection of surgical procedures for obese patients with OSAS, especially those with concomitant GERD.

图1 肥胖合并OSAS患者GERD的个体化术式决策流程注:OSAS为阻塞性睡眠呼吸暂停;GERD为胃食管反流病;LES:为食管下括约肌;RYGB为Roux-en-Y胃旁路术。
表2 RYGB与LSG的机制比较
减重术式 RYGB LSG
起效速度 极快,对血糖的改善常在术后数日内发生,远早于显著体质量下降 快,对血糖的改善迅速,前驱期略长于RYGB。
核心作用权重 强效的体质量非依赖机制与体质量依赖机制并重。肠源性机制作用尤为突出。 以体质量依赖机制为主,兼具重要的非体质量依赖机制。
主要效应激素 GLP-1\PYY餐后水平急剧、持久升高,效应强于LSG。胃泌素餐后反应较弱。 Ghrelin水平极度被抑制,是其核心作用。GLP-1\PYY餐后水平显著升高。
核心机制路径 食物快速抵达远端肠道,产生强效促胰液素效应,通过胆汁绕行强力激活远端肠道。 因切除胃底,极度抑制食物Ghrelin,同时促进食物与肠道接触,增强促胰液素的效应,限制食物摄入。
胆汁酸代谢 胆汁酸总量显著增加,成分发生改变,胆汁酸绕行十二指肠接触强力激活FXR和TGR5受体。 胆汁酸同样增加,但程度弱于RYGB,主要通过胃排空加速间接影响肠肝循环。
临床应用 对2型糖尿病、严重胰岛素抵抗患者效果更佳,缺点在于手术操作较复杂,长期营养风险较高,需严格随访。 对2型糖尿病有高缓解率,手术操作简单,营养并发症风险较低,但存在胃食管反流风险。
对OSAS缓解及间接效应 通过高效减重大幅度改善上呼吸道结构,缓解间歇性低氧和睡眠紊乱,从而减少氧化应激与系统性炎症间接改善胰岛素抵抗。 通过减重改善上气道解剖结构,有效缓解间歇性低氧和睡眠紊乱,间接促进代谢改善。
1
王云,何燕,刘师节,等. 阻塞性睡眠呼吸暂停低通气综合征与糖脂代谢紊乱的机制研究进展 [J]. 中国全科医学2022, 25(2):243-247.
2
Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome [J]. J Am Coll Cardiol, 2013, 62 (7):569-576.
3
Borges P, Miguel S, Barcelos A, et al. Obstructive sleep apnea improvement in patients undergoing bariatric surgery: a prospective study [J]. Sleep Med, 2020, 75:395-400.
4
Ashrafian H, Toma T, Rowland SP, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric surgery [J]. Thorax, 2015, 70 (5):499-500.
5
Cao P, Li J, Wang G, et al. Effects of sleeve gastrectomy on populations with obesity and obstructive sleep apnea: a meta-analysis [J]. Surg Obes Relat Dis, 2025, 21 (3):288-300.
6
Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults [J]. JAMA, 2004, 291 (16):2013-2016.
7
文艺,谢世麒,周建荣,等. 阻塞性睡眠呼吸暂停低通气综合征合并超重或肥胖的临床特征及影响因素研究 [J]. 重庆医科大学学报2023, 48 (11):1387-1392.
8
张子月,鲁宏华,林鹏. 阻塞性睡眠呼吸暂停低通气综合征合并睡行症一例 [J]. 中华结核和呼吸杂志2017, 40 (05):378-379.
9
蒋雪龙,何忠明,李剑平,等. 高海拔对睡眠呼吸暂停综合征患者的影响 [J]. 国际呼吸杂志2016, 36 (16):1277-1280.
10
Wang Q, Zeng H, Dai J, et al. Association between obstructive sleep apnea and multiple adverse clinical outcomes: evidence from an umbrella review [J]. Front Med (Lausanne), 2025, 12:1497703.
11
Schwartz AR, Patil SP, Laffan AM, et al. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches [J]. Proc Am Thorac Soc, 2008, 5 (2):185-192.
12
Ryan S, Arnaud C. Inflammation and sleep apnea: an update [J]. Chest, 2018, 154 (1):204-215.
13
Lévy P, Kohler M, Mcnicholas WT, et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives [J]. Eur Respir J, 2015, 46 (1):47-63.
14
Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome [J]. J Am Coll Cardiol, 2013, 62 (7):569-576.
15
Mesarwi OA, Punjabi NM, Polotsky VY. Metabolic dysfunction in obstructive sleep apnea: a critical examination of the mechanisms [J]. Sleep Med Rev, 2019, 47:1-13.
16
Gagner M, Hutchinson C, Rosenthal R. Is laparoscopic sleeve gastrectomy a standalone procedure?[J]. Obes Surg, 2020, 30 (1):256-263.
17
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity [J]. JAMA, 2018, 319 (3):241-254.
18
Borges P, Miguel S, Barcelos A, et al. Obstructive sleep apnea improvement in patients undergoing bariatric surgery: a prospective study [J]. Sleep Med, 2020, 75:395-400.
19
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes [J]. N Engl J Med, 2017, 376 (7):641-651.
20
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014 [J]. Obes Surg, 2017, 27 (9):2279-2289.
21
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass [J]. N Engl J Med, 2017, 377 (12):1143-1155. doi:10.1056/NEJMoa1700459.
22
Ashrafian H, Toma T, Rowland SP, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric surgery [J]. Thorax, 2015, 70 (5):499-500.
23
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations [J]. Diabetes Care, 2016, 39 (6):861-877.
24
Hany M, Zidan MH, Elhadidy MS, et al. Anatomical remodeling of the upper airway after laparoscopic sleeve gastrectomy: a multimodal assessment of structural and functional improvements in obstructive sleep apnea [J]. Obes Surg, 2025, 35 (12):5316-5335.
25
Adamo M, Brandimarti P, Costa G, et al. Reversal of obesity-induced hyperglycemia and improvement in insulin sensitivity by sleeve gastrectomy in mice are associated with increased adiponectin [J]. Diabetes, 2020, 69 (12):2647-2657.
26
Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery [J]. Diabetes Care, 2016, 39 (6):893-901.
27
买买提·依斯热依力,玉苏普江·伊明江,王永康,等. 袖状胃切除术调节GLP-1/DPP-4通路抑制肥胖症小鼠氧化应激诱导脂肪炎症的作用 [J]. 中国普通外科杂志2024, 33 (07):1100-1110.
28
Lampropoulos C, Mulita F, Alexandrides T, et al. Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study [J]. Menopause Rev, 2022, 21:97-105.
29
Grong E, Græslie H, Munkvold B, et al. Gastrin secretion after bariatric surgery—response to a protein-rich mixed meal following Roux-en-Y gastric bypass and sleeve gastrectomy: a pilot study in normoglycemic women [J]. Obes Surg, 2016, 26:1448-1456.
30
Rubino F, et al. The role of the small intestine in the pathophysiology of type 2 diabetes [J]. Diabetes Care, 2010, 33 (5):1153-1156.
31
Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery [J]. Diabetes Care, 2016, 39 (6):893-901.
32
Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus [J]. Obes Surg, 2004, 14:606-612.
33
Anderson B, Switzer NJ, Almamar A, et al. The impact of laparoscopic sleeve gastrectomy on plasma ghrelin levels: a systematic review [J]. Obes Surg, 2013, 23:1476-1480.
34
Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers [J]. J Appl Physiol, 2009, 106 (5):1538-1544.
35
Lévy P, Kohler M, Mcnicholas WT, et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives [J]. Eur Respir J, 2015, 46 (1):47-63.
36
Li Y, Zhang W, Wang J, et al. Association between obstructive sleep apnea and gastroesophageal reflux disease: a systematic review and meta-analysis [J]. Sleep Med Rev, 2023, 69:101789.
37
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux [J]. World J Gastroenterol, 2015, 21 (36):10348-10357.
38
康星,夏雪峰,俞杭,等. 袖状胃切除术、单吻合口胃旁路术、袖状胃切除联合胃空肠吻合术治疗肥胖合并胃食管反流的疗效分析 [J/OL]. 中华胃食管反流病电子杂志2025, 12 (1):10-16. DOI:10.3877/cma.j.issn.2095-8765.2025.01.002.
39
Santoro G, Alfred J, Rehman A, et al. Revisional bariatric surgery following sleeve gastrectomy: a meta-analysis comparing Roux-en-Y gastric bypass and one anastomosis gastric bypass[J]. Ann R Coll Surg Engl, 2025, 107(3): 180-187.
40
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss and comorbidities in patients with morbid obesity: the SM-BOSS randomized clinical trial [J]. JAMA, 2018, 319 (3):241-254.
[1] 邢浴泽, 李全, 曹胜军. 多组学技术在烧伤合并脓毒症诊疗中的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(03): 223-228.
[2] 孟凡华, 杨成文, 杨立峥. 不同年龄段肺炎支原体肺炎患儿乳酸脱氢酶水平与肝功能异常及糖代谢特征的关系[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(02): 114-121.
[3] 张翊乔, 李梦伊, 刘洋, 张鹏, 张忠涛. 我国腹腔镜减重代谢手术治疗现状与未来[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 1-4.
[4] 王伦, 周昕, 宁伟伟, 杨清旭, 胡旭, 何诣航, 谢铭. 我国腹腔镜减重代谢手术后营养不良及管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 9-11.
[5] 康星, 俞杭, 单晓东, 孙喜太, 褚薛慧. 单孔腹腔镜袖状胃切除术围手术期血液管理措施的比较研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 18-21.
[6] 刘辉, 谢周洲, 周晓琪, 张桂豪, 江惠明, 陈南辉. 靶向SOAT1对前列腺癌的作用和机制研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 95-101.
[7] 王家轩, 苟浩博, 魏秋亚, 高田宇, 樊勇. 单孔袖状胃切除联合单吻合口胃回肠转流术的临床疗效[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(02): 110-114.
[8] 倪玮峰, 田文扬, 倪雨玲, 杨海宁, 施岳柱. 脂质代谢在七氟烷与丙泊酚麻醉对老年结直肠癌患者认知功能中的作用[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 173-178.
[9] 马博, 李涛, 董扬帆, 商少华, 马华, 王俊, 纪文静. 减重代谢手术改善2型糖尿病肥胖患者胃肠肽及血糖的前瞻性研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 53-60.
[10] 代聪聪, 邬宏伟, 高一, 周琪, 户占飞, 李海波, 宋健楠. 一碳代谢在认知障碍中的作用机制及研究进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(02): 145-150.
[11] 周志勇, 姜福金, 王苏贵. 脂溶性维生素通过肠肾轴调控肾结石的机制研究进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(02): 151-157.
[12] 杨磊, 熊见武, 沈宗文, 陈熊熊, 李滢旭. 腹腔镜胃袖状切除术后门静脉-肠系膜静脉血栓形成1例报道[J/OL]. 中华肥胖与代谢病电子杂志, 2026, 12(01): 72-77.
[13] 宋保华, 王斌, 帅青青, 张秀芝. 基于NHANES数据库的淋巴细胞-高密度脂蛋白胆固醇比值和代谢功能障碍相关脂肪性肝病的关系和阈值效应研究[J/OL]. 中华肥胖与代谢病电子杂志, 2026, 12(01): 1-8.
[14] 李转霞, 张梅, 周沁, 李林娟. 连续葡萄糖监测指标与阻塞性睡眠呼吸暂停严重程度相关性研究[J/OL]. 中华肥胖与代谢病电子杂志, 2026, 12(01): 16-22.
[15] 卓琳, 周灵丽, 刘炫, 蒋华杰, 马莉, 崔景秋, 汪秀英. 绝经前女性高尿酸血症相关因素及效应关系研究[J/OL]. 中华肥胖与代谢病电子杂志, 2026, 12(01): 23-30.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?